(PharmaNewsWire.Com, December 22, 2017 ) A fresh report has been added to the wide database of Market Research Hub (MRH) titled “Global Choroidal Neovascularization Drug Market Research Report (2017-2021)” which provides an outlook of current market value as well as the expected forecast of Rate on Investment (ROI) with growing CAGR of XX% during stated forecast from 2017-2022. The report studies the choroidal neovascularization drug market worldwide, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, size, growth, revenue, consumption, import and export in these regions.
Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Choroidal Neovascularization Drug for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India
Global Choroidal Neovascularization Drug market competition by top manufacturers/players, with Choroidal Neovascularization Drug sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including Cellphire, Inc. Chrysalis BioTherapeutics, Inc. Cleveland BioLabs, Inc. Cumberland Pharmaceuticals, Inc. Diffusion Pharmaceuticals Inc. Eli Lilly and Company GNI Group Ltd. Humanetics Corporation INSYS Therapeutics, Inc. Meabco A/S Neumedicines Inc. Onconova Therapeutics, Inc. PharmaIN Corporation Pluristem Therapeutics Inc. ProCertus BioPharm Inc. RDD Pharma Ltd. RedHill Biopharma Ltd. RxBio, Inc. Soligenix, Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into AVMOC-001 BB-3 BBT-007 DG-3 Entolimod EWA-001 Others
Table of Content: Global Choroidal Neovascularization Drug Sales Market Report 2017 1 Choroidal Neovascularization Drug Market Overview 1.1 Product Overview and Scope of Choroidal Neovascularization Drug 1.2 Classification of Choroidal Neovascularization Drug by Product Category 1.2.1 Global Choroidal Neovascularization Drug Market Size (Sales) Comparison by Type (2012-2022) 1.2.2 Global Choroidal Neovascularization Drug Market Size (Sales) Market Share by Type (Product Category) in 2016 1.2.3 AVMOC-001 1.2.4 BB-3 1.2.5 BBT-007 1.2.6 DG-3 1.2.7 Entolimod 1.2.8 EWA-001 1.2.9 Others 1.3 Global Choroidal Neovascularization Drug Market by Application/End Users 1.3.1 Global Choroidal Neovascularization Drug Sales (Volume) and Market Share Comparison by Application (2012-2022) 1.3.2 Clinic 1.3.3 Hospital 1.3.4 Others 1.4 Global Choroidal Neovascularization Drug Market by Region 1.4.1 Global Choroidal Neovascularization Drug Market Size (Value) Comparison by Region (2012-2022) 1.4.2 United States Choroidal Neovascularization Drug Status and Prospect (2012-2022) 1.4.3 China Choroidal Neovascularization Drug Status and Prospect (2012-2022) 1.4.4 Europe Choroidal Neovascularization Drug Status and Prospect (2012-2022) 1.4.5 Japan Choroidal Neovascularization Drug Status and Prospect (2012-2022) 1.4.6 Southeast Asia Choroidal Neovascularization Drug Status and Prospect (2012-2022) 1.4.7 India Choroidal Neovascularization Drug Status and Prospect (2012-2022) 1.5 Global Market Size (Value and Volume) of Choroidal Neovascularization Drug (2012-2022) 1.5.1 Global Choroidal Neovascularization Drug Sales and Growth Rate (2012-2022) 1.5.2 Global Choroidal Neovascularization Drug Revenue and Growth Rate (2012-2022)
2 Global Choroidal Neovascularization Drug Competition by Players/Suppliers, Type and Application 2.1 Global Choroidal Neovascularization Drug Market Competition by Players/Suppliers 2.1.1 Global Choroidal Neovascularization Drug Sales and Market Share of Key Players/Suppliers (2012-2017) 2.1.2 Global Choroidal Neovascularization Drug Revenue and Share by Players/Suppliers (2012-2017) 2.2 Global Choroidal Neovascularization Drug (Volume and Value) by Type 2.2.1 Global Choroidal Neovascularization Drug Sales and Market Share by Type (2012-2017) 2.2.2 Global Choroidal Neovascularization Drug Revenue and Market Share by Type (2012-2017) 2.3 Global Choroidal Neovascularization Drug (Volume and Value) by Region 2.3.1 Global Choroidal Neovascularization Drug Sales and Market Share by Region (2012-2017) 2.3.2 Global Choroidal Neovascularization Drug Revenue and Market Share by Region (2012-2017) 2.4 Global Choroidal Neovascularization Drug (Volume) by Application
3 United States Choroidal Neovascularization Drug (Volume, Value and Sales Price) 3.1 United States Choroidal Neovascularization Drug Sales and Value (2012-2017) 3.1.1 United States Choroidal Neovascularization Drug Sales and Growth Rate (2012-2017) 3.1.2 United States Choroidal Neovascularization Drug Revenue and Growth Rate (2012-2017) 3.1.3 United States Choroidal Neovascularization Drug Sales Price Trend (2012-2017) 3.2 United States Choroidal Neovascularization Drug Sales Volume and Market Share by Players 3.3 United States Choroidal Neovascularization Drug Sales Volume and Market Share by Type 3.4 United States Choroidal Neovascularization Drug Sales Volume and Market Share by Application
About Market Research Hub: Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of pharmaceutical research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients and customers.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
